Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00869206 · FLOW

Participant flow

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement · Source last updated 2018-11-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Patients receive zoledronic acid IV over at least 15 minutes every 4 weeks for up to 2 years in the absence of disease progression or unacceptable toxicity.
    id
    FG000
    title
    Arm I (Zoledronic Acid Every 4 Weeks)
  2. description
    Patients receive zoledronic acid IV over at least 15 minutes every 12 weeks for up to 2 years in the absence of disease progression or unacceptable toxicity.
    id
    FG001
    title
    Arm II (Zoledronic Acid Every 12 Weeks)
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        911
      2. group Id
        FG001
        num Subjects
        911
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        882
      2. group Id
        FG001
        num Subjects
        884
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        29
      2. group Id
        FG001
        num Subjects
        27
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Patients receive zoledronic acid IV over at least 15 minutes every 4 weeks for up to 2 years in the absence of disease progression or unacceptable toxicity.
    id
    FG000
    title
    Arm I (Zoledronic Acid Every 4 Weeks)
  2. description
    Patients receive zoledronic acid IV over at least 15 minutes every 12 weeks for up to 2 years in the absence of disease progression or unacceptable toxicity.
    id
    FG001
    title
    Arm II (Zoledronic Acid Every 12 Weeks)
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        911
      2. group Id
        FG001
        num Subjects
        911
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        882
      2. group Id
        FG001
        num Subjects
        884
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        29
      2. group Id
        FG001
        num Subjects
        27
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice